Effectiveness of ALB-PRF With Two Types of Bone Grafts With Putty Form Around Immediate Dental Implants.
NCT ID: NCT06643468
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
60 participants
INTERVENTIONAL
2024-08-14
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Researchers will compare the ALB- PRF membrane extracted from patient blood with synthetic collagen membrane in addition to the putty form bone graft The main questions it aims to answer are:
Is the ALB-PRF is considered suitable alternative to synthetic collagen membrane in GBR techniques? also, growth factors releasing form ALB-PRF can continue over 21 days.
Participants will:
receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and collagen as membrane. Also, in other hand participant will receive immediate implant with beta-tricalcium phosphate + calcium sulphate as bone graft and collagen as membrane. and compered with participants receive the same bone and implant technique except for ALB-PRF membrane instead of collagen.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Customized Zirconia Sheet vs PTFE as a Non-resorbable Barrier in Maxillary Alveolar Ridge Augmentation
NCT06227455
Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts: Randomized Controlled Clinical Trial
NCT06653868
Changes of Soft and Hard Tissues After Alveolar Ridge Preservation: Freeze-dried Bone Allograft vs. L-PRF Clot
NCT03331185
Evaluation of Mineralized Plasmatic Matrix With and Without Collagen Membrane in Peri-implant Bone Regeneration
NCT04816110
The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
NCT03468998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion criteria:
* Patient between 20-40 years old.
* Unrestorable maxillary tooth/ teeth in the aesthetic zone.
* Adequate keratinized soft tissue.
* Favorable pattern of occlusion.
* Good oral hygiene.
* Patient ability to comply with the required recall visits.
* Patients with type II socket.
Exclusion Criteria:
* Local or systemic diseases that contraindicate implant placement or surgery.
* Smokers
* Patients with parafunctional habits.
Study design:
Selected participants will receive forty implants that will be placed immediately after extraction of unrestorable maxillary tooth/ teeth in the aesthetic zone. According to the type of the used bone graft and membrane, the participants will be randomly divided into 4 equal groups:
Group I: will include 10 patients, in which participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and collagen as membrane. Group II: will include 10 patients, in which participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate as bone graft and collagen as membrane.
Group III: will include 10 patients, in which participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and ALB- PRF as membrane. Group IV: will include 10 patients, in which participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate as bone graft and ALB- PRF as membrane.
Procedures:
Pre-surgical phase:
* Pre-operative CBCT will be used to evaluate the mesiodistal width (inter-radicular distance), residual bone beyond the apex, socket width and root angulation.
* Study cast analysis to evaluate teeth inclinations, inter-arch space and occlusion. - Diagnostic waxing up of missing tooth.
* Premedication: Patients will be premedicated by Amoxicillin 2 gm one hour before surgery as a prophylactic antibiotic, in addition patient will instructed to rinse with a 0.2% chlorhexidine mouth wash for 1 minute immediately prior to surgery.
Surgical phase:
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade Minimally vertical releasing incision.
4. Implant placement with copious irrigation.
5. Membranes placement: either ALB-PRF or collagen followed by insertion of putty form of bone graft materials according to the study design.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
Post-surgical instruction:
* Patients will be instructed to use 0.2% chlorhexidine gluconate mouth wash for 1 minute twice a day for 2 weeks.
* Patients will be maintained on amoxicillin 1gm twice a day for six days postoperatively.
* Ibuprofen 400 mg will be prescribed to be taken 2 to 4 times a day during meals as analgesic.
Loading on implant will be done four months after the implant insertion.
Evaluation:
I) Clinical Evaluation: all the following clinical parameters will be reassessed at 0,6,12 months.
1. Esthetics:
Will be evaluated according to pink esthetic score (PES).
2. Peri-implant pocket depth:
The distance between the base of the pocket and the gingival margin will be measured using a graduated plastic probe.
3. Plaque index (PI) :
Plaque index will be taken as an indicator for the patient oral hygiene.
4. Implant stability evaluation:
Using Resonance Frequency Analysis device (Osstell), implant stability will be assessed in both groups at baseline, 6 months , and 12 months postoperative
5. Modified bleeding index. Modified bleeding index will be taken as an indicator gingival inflammation.
II) Radiographic Evaluation:
Using cone beam CT (CBCT) scan, the changes in the marginal bone level and the thickness of buccal plate will be measured at baseline, 6 months and 12 months postoperative.
III) Laboratory analysis :
Samples will be collected using sterile paper strip at day of surgery, one, two, four, and eight weeks postoperatively for analysis of the growth factors concentration according to manufacture instruction using multiplex immunoassay.
Statistical analysis:
The data will be collected and statistical analysis will be done
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
beta-tricalcium phosphate + calcium sulphate bone graft and collagen membrane
will include 10 patients, in which participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate as bone graft and collagen as membrane.
participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate bone graft and collagen membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: collagen followed by insertion of eta-tricalcium phosphate + calcium sulphate bone graft.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
beta-tricalcium phosphate + calcium sulphate bone graft and ALB- PRF membrane
will include 10 patients, in which participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate as bone graft and ALB- PRF as membrane.
participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate bone graft and ALB-PRF membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: ALB-PRF followed by insertion of eta-tricalcium phosphate + calcium sulphate bone graft.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing
nano-crystalline putty hydroxyapatite bone graft and collagen membrane
will include 10 patients, in which participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and collagen as membrane.
participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and collagen membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: collagen followed by insertion of nano-crystalline putty hydroxyapatite.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
nano-crystalline putty hydroxyapatite bone graft and ALB- PRF membrane
will include 10 patients, in which participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and ALB- PRF as membrane.
participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and ALB- PRF as membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade without vertical releasing incision.
4. Implant placement with copious irrigation.
5. Membranes placement: ALB-PRF followed by insertion of nano-crystalline putty hydroxyapatite..
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and collagen membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: collagen followed by insertion of nano-crystalline putty hydroxyapatite.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
participants will receive immediate implant with nano-crystalline putty hydroxyapatite as bone graft and ALB- PRF as membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade without vertical releasing incision.
4. Implant placement with copious irrigation.
5. Membranes placement: ALB-PRF followed by insertion of nano-crystalline putty hydroxyapatite..
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate bone graft and collagen membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: collagen followed by insertion of eta-tricalcium phosphate + calcium sulphate bone graft.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing abutment.
participants will receive immediate implant with beta-tricalcium phosphate + calcium sulphate bone graft and ALB-PRF membrane.
1. Injection of local anesthetic Articaine hydrochloride 4% with Epinephrine (1:100,000).
2. Atraumatic removal of remaining root or tooth then implant will be placed according to the standard protocol.
3. Sulcular incision with be made 15c blade .
4. Implant placement with copious irrigation.
5. Membranes placement: ALB-PRF followed by insertion of eta-tricalcium phosphate + calcium sulphate bone graft.
6. Customized healing abutment application.
7. Suturing of wound edges with 0.5 suture around the customized healing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unrestorable maxillary tooth/ teeth in the aesthetic zone.
* Adequate keratinized soft tissue.
* Favorable pattern of occlusion.
* Good oral hygiene.
* Patient ability to comply with the required recall visits.
* Patients with type II socket.
Exclusion Criteria
* Smokers
* Patients with parafunctional habits.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hamzah Abdulatef Mansoor
B.D.S, M.S, Master Degree of Oral Medicine & Periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of dentistry Mansoura university ,
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A02090230M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.